Choice ClinOps published an analysis exploring what developments mean operationally, including what changes with in-vivo CAR-T and why trial pauses are clinical operations stress tests.
Published
Signal category
Research & Knowledge
Quote
“I explored what these developments mean operationally, including what changes with in-vivo CAR-T and why trial pauses are really clinical operations stress tests.”
— Leila Cupersmith|Choice ClinOps team
Company
Choice ClinOps
Sponsor-side fractional clinical operations leadership for governance, study rescue, and M&A trial continuity
- Industry
- Strategic Management Services
- Location
- Princeton, US
- Company size
- 1 employees
Choice ClinOps is the fractional clinical operations command center for small–mid oncology and rare-disease sponsors. We deliver strategic operational leadership, fast study rescue, and unified sponsor–CRO–vendor–site governance across the U.S. and priority global regions—reducing overspend, eliminating delays, and accelerating the milestones that matter most. Sponsors partner with us before and when timelines slip, vendor performance declines, global startup stalls, or internal operational leadership gaps threaten budget burn and valuation. Our model replaces high-cost, hard-to-hire senior operations roles with embedded executive-level leadership—at a fractional cost and with Big-Pharma execution quality. Core Areas of Impact: * Fractional Senior Clinical Operations Leadership (Sr. PM, Head of ClinOps, PMO) * Study Rescue & Operational Turnaround (30-day diagnostic + execution support) * Sponsor–CRO–Vendor–Site Alignment & Governance * Global Strategy + High-Value ex-US Oversight (oncology and rare) * Startup Acceleration & Risk Mitigation * Enrollment Optimization for Oncology & Rare-Disease Trials * M&A Operational Continuity & Change Management * Patient & Caregiver–Aligned Operational Design Our approach - proven for over 20 years - improves global study clinical trial operations, vendor performance, restores cross-functional alignment, strengthens site engagement, and protects capital during critical clinical development phases. The result: - Lower burn rate - Fewer operational errors - Faster activation - Better enrollment - Higher study predictability - Stronger patient/caregiver trust - More confident fundraising and partnership conversations - A trial that moves—not stalls If your study requires operational precision, global coordination, and measurable ROI without the overhead of a large CRO or additional full-time headcount, we can meet your need. Lean Team. Global Delivery. www.choiceclinops.com
Founded 2024